Evidence map›Paper›PMID 38633396›Full record

ArticleInfectious diseases & clinical microbiology2022

An Unusual Cause of Acute Isolated Hepatitis in a Cancer Patient Post-COVID Pneumonia: HSV-2.

Türkkan Öztürk-Kaygusuz, Ayşe Sağmak-Tartar, Ayhan Akbulut

Open access · greenAbstract readCase Reports
In one paragraph

Article in Infectious diseases & clinical microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 74% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Türkkan Öztürk-KaygusuzDepartment of Infectious Diseases and Clinical Microbiology, Fırat University School of Medicine, Elazığ, Turkey.ORCID https://orcid.org/0000-0002-4151-5903
Ayşe Sağmak-TartarDepartment of Infectious Diseases and Clinical Microbiology, Fırat University School of Medicine, Elazığ, Turkey.ORCID https://orcid.org/0000-0002-9052-7986
Ayhan AkbulutDepartment of Infectious Diseases and Clinical Microbiology, Fırat University School of Medicine, Elazığ, Turkey.ORCID https://orcid.org/0000-0003-2560-3265
Fırat University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herpes simplex virus is a rare cause of hepatitis in immunosuppressed and immunocompetent individuals. It can cause clinical pictures in patients ranging from an asymptomatic course to fatal acute fulminant hepatitis. Early diagnosis and treatment may be delayed if it is not suspected because of the patients' nonspecific clinic. This study presents a case of isolated HSV-2 hepatitis in a patient with a history of cancer chemotherapy and a recent diagnosis of COVID-19 who received steroid therapy.

Indexed as

COVID-19hepatitisherpes simplex virus-2herpes simplex virus infections

Identifiers

PMID38633396
PMCPMC10986694
OpenAlexW4394920255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.